Topological modification of interleukin-2 and application of interleukin-2 as autoimmune disease medicine

The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the invention, the interleukin-2 is subjected to topological transformation, so that the interleukin-2 with a cyclic or isohydrocarbon topological...

Full description

Saved in:
Bibliographic Details
Main Authors HE JING, XIAO XIAN, TIAN XIBAO, ZHANG WENBIN, LI ZHANGUO, FENG RUILING, FANG JING
Format Patent
LanguageChinese
English
Published 07.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the invention, the interleukin-2 is subjected to topological transformation, so that the interleukin-2 with a cyclic or isohydrocarbon topological structure of targeted activated Treg is obtained. The affinity of the interleukin-2 with the cyclic or Soxhlet-hydrocarbon structure and a receptor is not changed, the half-life period of the medicine can be prolonged, the stability can be enhanced, the dosage of long-term medication and the medication frequency can be reduced, and the effect of inhibiting immunity can be achieved. As a long-acting immunosuppressor, the interleukin-2 topological transformation protein disclosed by the invention is beneficial to treatment of various autoimmune diseases. 本发明公开了白细胞介素-2的拓扑改造及其作为自身免疫病药物的应用。本发明对白细胞介素-2进行拓扑改造,获得了靶向性激活Treg的环状或索烃拓扑结构的白细胞介素-2。环状或索烃结构的白细胞介素-2不改变其与受体的亲和性,同时可以延长药物的半衰期,增强稳定性,减少长期用药的剂量和用药次数,发挥抑制免疫的效果。本发明的白细胞介素-2拓
AbstractList The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the invention, the interleukin-2 is subjected to topological transformation, so that the interleukin-2 with a cyclic or isohydrocarbon topological structure of targeted activated Treg is obtained. The affinity of the interleukin-2 with the cyclic or Soxhlet-hydrocarbon structure and a receptor is not changed, the half-life period of the medicine can be prolonged, the stability can be enhanced, the dosage of long-term medication and the medication frequency can be reduced, and the effect of inhibiting immunity can be achieved. As a long-acting immunosuppressor, the interleukin-2 topological transformation protein disclosed by the invention is beneficial to treatment of various autoimmune diseases. 本发明公开了白细胞介素-2的拓扑改造及其作为自身免疫病药物的应用。本发明对白细胞介素-2进行拓扑改造,获得了靶向性激活Treg的环状或索烃拓扑结构的白细胞介素-2。环状或索烃结构的白细胞介素-2不改变其与受体的亲和性,同时可以延长药物的半衰期,增强稳定性,减少长期用药的剂量和用药次数,发挥抑制免疫的效果。本发明的白细胞介素-2拓
Author FANG JING
XIAO XIAN
TIAN XIBAO
ZHANG WENBIN
LI ZHANGUO
HE JING
FENG RUILING
Author_xml – fullname: HE JING
– fullname: XIAO XIAN
– fullname: TIAN XIBAO
– fullname: ZHANG WENBIN
– fullname: LI ZHANGUO
– fullname: FENG RUILING
– fullname: FANG JING
BookMark eNqNyrsKAjEQQNEUWvj6h_EDFvaBaCuLYmW1_TIkExlMZoJJ_l8LW8Hq3uKszUJUaGV40qRBH2wxQFTH_nOFVUA9sBR6BapPlqYHFAeYUvgNMmAtyjFWIXCcCTNBJMeWhbZm6TFk2n27MfvrZRpvDSWdKSe0JFTm8d51x7YdTof-PPxj3sTZQo4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 白细胞介素-2的拓扑改造及其作为自身免疫病药物的应用
ExternalDocumentID CN117003852A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN117003852A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:54:55 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN117003852A3
Notes Application Number: CN202310827760
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231107&DB=EPODOC&CC=CN&NR=117003852A
ParticipantIDs epo_espacenet_CN117003852A
PublicationCentury 2000
PublicationDate 20231107
PublicationDateYYYYMMDD 2023-11-07
PublicationDate_xml – month: 11
  year: 2023
  text: 20231107
  day: 07
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies PEKING UNIVERSITY
RelatedCompanies_xml – name: PEKING UNIVERSITY
Score 3.6149006
Snippet The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Topological modification of interleukin-2 and application of interleukin-2 as autoimmune disease medicine
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231107&DB=EPODOC&locale=&CC=CN&NR=117003852A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjStyLrsq17KOLSjSHYDZmyt5H0A-tHO9YWwb_eu9i5PahvIQkhOXK5u_zuA-CqHUrFbRmZeBm4yf3AMqUdcBOFu93t-IrjMHlbeO3hI7-btqYVeFnGwug8oR86OSJylI_8nuv3er76xHK1b2V2rWLsSm8GE8c1SusYlRUqour2nP545I6EIYQjPMN7cKjACoFg1u0GbJIaTXn2-089ikqZr4uUwR5sjXG1JN-HyudzDXbEsvJaDbbvS8AbmyXvZQcQT77rGRBV2XsakI-P3ilLI0ZZHxZvYfEaJ6bFZBKwNWT6lwkZk0WexhQcErISpGFLnP0QLgf9iRiauOfZD4Fmwlsdr3kE1SRNwmNg3WbQ8NFcUBEqPZYfqhaPIku2lGyQFWOfQP3vder_DZ7CLhFbx-R1zqCaL4rwHIVzri40Vb8AMCmVyA
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUYP4VRPD22IYBcbDYqSDoMIgZhreSLuPOD82AltM_Ovt1U14UN-atmnaS6931999AFy2fC6owQNNXgaqUdfTNW54VJPC3ei0XUHlMHpb2K3BI72bNqcFeMljYVSe0A-VHFFylCv5PVHv9Xz1iWUp38rllQhlV3zdd0yrllnHUlnBIqpW1-xNxtaY1RgzmV2zH0wssIIgmH6zAZttzM6LqtNTF6NS5usipb8LWxO5WpTsQeHzuQwllldeK8P2KAO8ZTPjveU-hM53PQOkKnmPPfTxUTslcUAw68PizU9fw0jTCY88soZM_zJhSXiaxCEGh_gkA2lIjrMfwEW_57CBJvc8-yHQjNmr4zUOoRjFkV8B0ml4dVeaCyKQSo_u-qJJg0DnTcHraMUYR1D9e53qf4PnUBo4o-FseGvfH8MOEl7F57VPoJgsUv9UCupEnCkKfwFbCZi1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Topological+modification+of+interleukin-2+and+application+of+interleukin-2+as+autoimmune+disease+medicine&rft.inventor=HE+JING&rft.inventor=XIAO+XIAN&rft.inventor=TIAN+XIBAO&rft.inventor=ZHANG+WENBIN&rft.inventor=LI+ZHANGUO&rft.inventor=FENG+RUILING&rft.inventor=FANG+JING&rft.date=2023-11-07&rft.externalDBID=A&rft.externalDocID=CN117003852A